ArticleInternational journal of oncology2022
CYP11A1‑derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas.
Open access · bronzeAbstract read
In one paragraph
Article in International journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- Serum vitamin D levels and acute kidney injury: a systemic review and meta-analysis.Scientific reports · 2022Pooled it
- Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro.Journal of bone oncology · 2026Article
- VDR Activation Suppresses Pancreatic Cancer Metastasis Through Inhibition of the ERK Signaling Pathway.Cancers · 2026Article
- Hepatocellular carcinoma and vitamin D metabolism: novel targets and therapeutic strategies.Cellular oncology (Dordrecht, Netherlands) · 2026Review
- Calcitriol and hyperthermia potentiate gemcitabine efficacy - A Multifactorial Preclinical Evaluation in Pancreatic and Breast Cancer.Research square · 2025Article
- Recent Advancements Towards the Use of Vitamin D Isoforms and the Development of Their Synthetic Analogues as New Therapeutics.Biomedicines · 2025Review
- The vitamin DAmerican journal of physiology. Cell physiology · 2025Article
- Porcupine expression promotes the progression of oral carcinogenesis.Neoplasia (New York, N.Y.) · 2025Article
- Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin.The Journal of investigative dermatology · 2024Review
- Functional characterization of theHeliyon · 2024Article
- Vitamin D-metabolizing enzyme CYP24A1 affects oncogenic behaviors of oral squamous cell carcinoma and its prognostic implication.Medical molecular morphology · 2024Article
- Antioxidant Functions of Vitamin D and CYP11A1-Derived Vitamin D, Tachysterol, and Lumisterol Metabolites: Mechanisms, Clinical Implications, and Future Directions.Antioxidants (Basel, Switzerland) · 2024Review
- Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment Options.Biomedicines · 2024Review
- Review
- Vitamin D: An Essential Nutrient in the Dual Relationship between Autoimmune Thyroid Diseases and Celiac Disease-A Comprehensive Review.Nutrients · 2024Review
- Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)Molecular and cellular endocrinology · 2024Article
- Article
- Article
- Recent Advances in Vitamin D Biology: Something New under the Sun.The Journal of investigative dermatology · 2023Article
- Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention.Antioxidants (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 4 institutions in 2 countries.
Andrzej T Slominski *Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Anna A Brożyna *Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Tae-Kang KimDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Mahmoud M ElsayedDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Zorica JanjetovicDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Shariq QayyumDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Radomir M SlominskiDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Allen S W OakDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Changzhao LiDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Ewa PodgorskaDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Wei LiDepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Anton M JettenCell Biology Section, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
Robert C TuckeySchool of Molecular Sciences, The University of Western Australia, Perth, Western Australia 6009, Australia.
Edith K Y TangSchool of Molecular Sciences, The University of Western Australia, Perth, Western Australia 6009, Australia.
Craig ElmetsDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
Mohammad AtharDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35292, USA.
University of Alabama at Birmingham · USUniversity of Western Australia · AUNational Institutes of Health · USUniversity of Tennessee Health Science Center · US
Funding
XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Omer Jamy · 1985 to 2026
$165.9MNuclear receptors: action, functions, and roles in diseaseZIAES101586 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI JETTEN, ANTON M · 2009 to 2025
$13.5MNRSA Training CoreTL1TR001880 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$10.0MRXR Rexinoids for Cancer ChemopreventionP01CA210946 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ATHAR, MOHAMMAD · 2017 to 2021
$7.3MMechanism of action and function of novel secosteroid 20(OH)D3 in the skinR01AR073004 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ANDRZEJ T SLOMINSKI · 2018 to 2026
$2.9MDual inhibition of MDM2 and XIAP as a therapeutic strategy in cancerR01CA240447 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LI, WEI, ZHOU, MUXIANG · 2020 to 2024
$2.7MSelective Targeting Survivin for Cancer TherapyR01CA193609 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LI, WEI · 2016 to 2020
$1.9MTopical Chemoprevention of Skin Cancer BiomarkersR01CA193885 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ELMETS, CRAIG A · 2016 to 2022
$1.7MSignificance of metabolic activation of lumisterol in the skinR01AR071189 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SLOMINSKI, ANDRZEJ T · 2017 to 2021
$1.6MCanonical and non-canonical vitamin D activation pathways in systemic lupusR21AI149267 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RAMAN, CHANDER, SLOMINSKI, ANDRZEJ T · 2020 to 2021
$408kUV Photodamage to the Skin: Prevention by Mutant p53 ImmunizationR21ES034595 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ELMETS, CRAIG A · 2022 to 2023
$408kBLRD VA I01 BX004293NCATS NIH HHS TL1 TR001880NCI NIH HHS P01 CA210946NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA193609NCI NIH HHS R01 CA193885NCI NIH HHS R01 CA240447NIAID NIH HHS R21 AI149267NIAMS NIH HHS R01 AR071189NIAMS NIH HHS R01 AR073004NIEHS NIH HHS R21 ES034595
Abstract
Hydroxyderivatives of vitamin D3, including classical 1,25(OH)
Indexed as
Basal Cell CarcinomaCarcinoma, Squamous CellCholesterol Side-Chain Cleavage EnzymeVitamin DAnimalsbeta CateninCholecalciferolHumansLow Density Lipoprotein Receptor-Related Protein-2MiceReceptors, CalcitriolSkin NeoplasmsZinc Finger Protein GLI1beta CateninCholecalciferolCholesterol Side-Chain Cleavage EnzymeLow Density Lipoprotein Receptor-Related Protein-2Receptors, CalcitriolVitamin DZinc Finger Protein GLI1basal cell carcinomakeratinocytesretinoid‑related orphan receptor αretinoid‑related orphan receptor γsquamous cell carcinomavitamin Dvitamin D receptor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.